Analyst Consensus ?
ConsensusBuy46 ratings
Bullish4087.0%
Neutral613.0%
Bearish00.0%
Live Nation Entertainment, Inc. · LYV · FY2024 Q3 · Calendar Q4 2024
Live Nation: Ticketing and concert growth support a strong Q4 setup
The supplied analysis supports a constructive operating thesis for Live Nation: ticketing, concerts, sponsorship, premium experiences, and venue expansion provide multiple growth avenues. The thesis is conditional because regulatory scrutiny, FX, spending, and execution risks could offset operating momentum; reported-versus-consensus comparisons are not available here.
Reported After market closeNYSECommunication Services
$39.87B market cap
80quality score
Earnings scorecard
Reported versus consensus
Reported EPS
—
Consensus $1.61
EPS surprise
—
Reported versus consensus
Reported revenue
—
Consensus $7.77B
Revenue surprise
—
Reported versus consensus
Market reaction
event-close to next-session close
Stock move
+4.7%
Event window
SPY move
-0.3%
Same window
Abnormal move
+5.1%
Stock minus SPY
Volume
3.1×
Versus trailing sessions
Subsequent drift
+3.9%
Up to 20 sessions
LYVSPY benchmark
Ask FN2 about LYV FY2024 Q3
Transcript, numbers and history already loaded
What drove LYV's +4.7% move after FY2024 Q3 earnings?What changed in LYV's guidance and outlook in FY2024 Q3?Give me the bull and bear case for LYV after FY2024 Q3 earnings.
Free account. Your question opens in FN2 with this report's transcript and numbers attached.
Transcript intelligence
What changed
Relative to the prior-quarter analysis, management continued to describe demand and the outlook as strong, while the latest analysis adds 15% Ticketmaster sales growth, 23% Concerts growth, 20% year-over-year sponsorship-partner growth, a $50 million CapEx increase for a new amphitheater, and a more detailed premium-inventory and technology-investment plan.
Guidance delta
Maintained; management continued to describe a strong Q4 and growth trajectory into 2025.
Key takeaways
- Management highlighted 15% year-over-year Ticketmaster sales growth and 23% Concerts growth.
- A large stadium and arena on-sale pipeline is expected to support Q4 volume.
- Sponsorship partners grew 20% year over year, while premium inventory and venue investment offer additional monetization opportunities.
- The market reaction was positive, but regulatory, FX, spending, and execution risks remain material.
Management priorities
- Execute the stadium and arena pipeline and deliver a strong Q4.
- Expand sponsorship revenue through global partner growth.
- Build or refurbish 14 venues and add premium fan inventory.
- Continue investment in Ticketmaster pricing, bot prevention, and marketing analytics.
Follow LYV with an agent that reads every filing, transcript, and price print. Free to start.
Try FN2 freeEarnings History
Estimate
Beat
Miss
Match
Analyst 52W Price Targets
$171.32Previous close
$82Low
$175.09Average
$222High
Latest persisted target per named analyst; persisted previous close from FN2's market snapshot as of Oct 14, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| Citigroup | Buy | Buy | Maintain | Aug 3, 2026 |
| Susquehanna | Neutral | Neutral | Maintain | Jul 31, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Guggenheim | Buy | Buy | Maintain | Jul 31, 2026 |
| BTIG | Buy | Buy | Maintain | Jul 31, 2026 |
| Bernstein | Outperform | Outperform | Maintain | Jul 31, 2026 |
| Benchmark | Buy | Buy | Maintain | Jul 31, 2026 |
| Citizens | Market Outperform | Market Outperform | Maintain | Jul 22, 2026 |
| JP Morgan | Overweight | Overweight | Maintain | Jul 21, 2026 |
| UBS | Buy | Buy | Maintain | Jul 20, 2026 |
| Wells Fargo | Overweight | Overweight | Maintain | Jul 9, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 9, 2026 |
| Morgan Stanley | Overweight | Overweight | Maintain | Jun 10, 2026 |
| Rothschild & Co | Buy | Neutral | Upgrade | Feb 27, 2026 |
| Evercore ISI Group | Outperform | Outperform | Maintain | Feb 20, 2026 |
| B of A Securities | Buy | Buy | Maintain | Feb 20, 2026 |
| Jefferies | Hold | Buy | Downgrade | Jan 13, 2026 |
| Roth Capital | Buy | Buy | Maintain | Nov 5, 2025 |
| Deutsche Bank | Buy | Buy | Maintain | Oct 23, 2025 |
| Seaport Global | Buy | Buy | Maintain | Sep 23, 2025 |
| Wolfe Research | Outperform | Outperform | Maintain | Jun 10, 2025 |
| Roth MKM | Buy | Buy | Maintain | May 2, 2025 |
| Rosenblatt | Buy | Buy | Maintain | May 2, 2025 |
| Macquarie | Outperform | Outperform | Maintain | Mar 6, 2025 |
| TD Cowen | Buy | Buy | Maintain | Nov 12, 2024 |
| Redburn Atlantic | Buy | Neutral | Upgrade | May 9, 2024 |
| Northcoast Research | Buy | Neutral | Upgrade | Mar 20, 2023 |
| Redburn Partners | Neutral | Neutral | Maintain | Nov 22, 2022 |
| Cowen & Co. | Outperform | Outperform | Maintain | Nov 2, 2021 |
| Gabelli & Co. | Buy | Buy | Maintain | Apr 14, 2020 |
| G.research | Buy | Buy | Maintain | Apr 14, 2020 |
| CFRA | Buy | Hold | Upgrade | Feb 28, 2020 |
| Atlantic Equities | Overweight | Overweight | Maintain | Jun 11, 2019 |
| Berenberg | Buy | Buy | Maintain | May 15, 2019 |
| BTIG Research | Buy | Neutral | Upgrade | Jul 24, 2018 |
| William Blair | Outperform | Outperform | Maintain | Jul 21, 2017 |
| Stephens & Co. | Overweight | Equal Weight | Upgrade | Nov 8, 2016 |
| Albert Fried | Overweight | Overweight | Maintain | Oct 30, 2015 |
| Maxim Group | Buy | Buy | Maintain | May 28, 2015 |
| Stifel Nicolaus | Buy | Hold | Upgrade | May 1, 2015 |
| Stifel | Buy | Hold | Upgrade | May 1, 2015 |
| MKM Partners | Buy | Buy | Maintain | Apr 9, 2015 |
| Albert Fried & Co. | Market Perform | Overweight | Downgrade | Mar 9, 2015 |
| Sterne Agee | Neutral | Buy | Downgrade | May 28, 2014 |
| ISI Group | Buy | Buy | Maintain | Feb 7, 2014 |
| Evercore Partners | Equal Weight | Equal Weight | Maintain | Mar 5, 2012 |
Named analyst price targets
Upside is calculated against the persisted previous close $171.32. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| Bernstein | Analyst unavailable | $220 | $169.64 | +28.4% | Oct 13, 2026 |
| Deutsche Bank | Analyst unavailable | $205 | $173.11 | +19.7% | Jul 31, 2026 |
| Susquehanna | Joseph Stauff | $187 | $174.24 | +9.2% | Jul 31, 2026 |
| Oppenheimer | Analyst unavailable | $210 | $173.26 | +22.6% | Jul 31, 2026 |
| Bernstein | Analyst unavailable | $215 | $183.59 | +25.5% | Jul 31, 2026 |
| Guggenheim | Curry Baker | $218 | $183.59 | +27.2% | Jul 31, 2026 |
| Roth Capital | Analyst unavailable | $208 | $183.59 | +21.4% | Jul 31, 2026 |
| Oppenheimer | Jed Kelly | $100 | $181.07 | -41.6% | Jul 28, 2026 |
| Oppenheimer | Jed Kelly | $200 | $179.4 | +16.7% | Jul 28, 2026 |
| BTIG | Analyst unavailable | $215 | $177.92 | +25.5% | Jul 23, 2026 |
| Susquehanna | Analyst unavailable | $186 | $180.86 | +8.6% | Jul 21, 2026 |
| UBS | Batya Levi | $208 | $180.22 | +21.4% | Jul 20, 2026 |
| Roth Capital | Analyst unavailable | $205 | $181.56 | +19.7% | Jul 15, 2026 |
| Wells Fargo | Analyst unavailable | $222 | $182.14 | +29.6% | Jul 9, 2026 |
| Goldman Sachs | Stephen Laszczyk | $202 | $182.14 | +17.9% | Jul 8, 2026 |
| Morgan Stanley | Analyst unavailable | $200 | $168.1 | +16.7% | Jun 10, 2026 |
| Guggenheim | Analyst unavailable | $197 | $157.26 | +15.0% | May 6, 2026 |
| Guggenheim | Curry Baker | $180 | $165.33 | +5.1% | Mar 9, 2026 |
| Goldman Sachs | Analyst unavailable | $175 | $162.67 | +2.1% | Feb 20, 2026 |
| Oppenheimer | Analyst unavailable | $190 | $165.3 | +10.9% | Feb 20, 2026 |
| Evercore ISI | Analyst unavailable | $198 | $166.63 | +15.6% | Feb 20, 2026 |
| Roth Capital | Analyst unavailable | $190 | $166.94 | +10.9% | Feb 20, 2026 |
| UBS | Analyst unavailable | $181 | $157.46 | +5.7% | Feb 20, 2026 |
| Morgan Stanley | Analyst unavailable | $185 | $157.46 | +8.0% | Feb 20, 2026 |
| Roth Capital | Analyst unavailable | $174 | $151.11 | +1.6% | Feb 12, 2026 |
| Jefferies | David Katz | $155 | $148.85 | -9.5% | Jan 13, 2026 |
| Evercore ISI | Vijay Jayant | $188 | $141.75 | +9.7% | Dec 23, 2025 |
| UBS | Analyst unavailable | $164 | $125.61 | -4.3% | Nov 25, 2025 |
| Evercore ISI | Kutgun Maral | $168 | $139.14 | -1.9% | Nov 5, 2025 |
| Roth Capital | Eric Handler | $176 | $138.68 | +2.7% | Nov 5, 2025 |
| Susquehanna | Analyst unavailable | $175 | $148.01 | +2.1% | Nov 3, 2025 |
| Deutsche Bank | Benjamin Soff | $173 | $156.15 | +1.0% | Oct 23, 2025 |
| Seaport Global | David Joyce | $190 | $163.82 | +10.9% | Sep 23, 2025 |
| MoffettNathanson | Robert Fishman | $195 | $161.1 | +13.8% | Aug 18, 2025 |
| Morgan Stanley | Cameron Mansson | $180 | $152.89 | +5.1% | Jul 24, 2025 |
| Susquehanna | Joseph Stauff | $165 | $143.71 | -3.7% | Jun 10, 2025 |
| Rosenblatt Securities | Barton Crockett | $146 | $92.18 | -14.8% | Nov 13, 2024 |
| Roth Capital | Eric Handler | $132 | $115.35 | -23.0% | Oct 16, 2024 |
| Seaport Global | David Joyce | $133 | $115.84 | -22.4% | Oct 15, 2024 |
| Oppenheimer | Jed Kelly | $120 | $94.2 | -30.0% | Sep 6, 2024 |
| Bank of America Securities | Peter Henderson | $125 | $95.34 | -27.0% | Sep 4, 2024 |
| Rosenblatt Securities | Barton Crockett | $123 | $94.77 | -28.2% | Jul 2, 2024 |
| Roth Capital | Eric Handler | $120 | $95.22 | -30.0% | May 24, 2024 |
| Seaport Global | David Joyce | $115 | $93.48 | -32.9% | May 24, 2024 |
| Macquarie | Paul Golding | $125 | $101.4 | -27.0% | May 23, 2024 |
| Guggenheim | Curry Baker | $128 | $92.21 | -25.3% | Apr 17, 2024 |
| Rosenblatt Securities | Barton Crockett | $119 | $101.42 | -30.5% | Apr 11, 2024 |
| Oppenheimer | Jed Kelly | $115 | $100.75 | -32.9% | Jul 28, 2023 |
| Oppenheimer | Jed Kelly | $110 | $98.28 | -35.8% | Jul 21, 2023 |
| Morgan Stanley | Analyst unavailable | $80 | $70.69 | -53.3% | Nov 30, 2022 |
| Citigroup | Analyst unavailable | $82 | $69.82 | -52.1% | Nov 28, 2022 |
| Macquarie | Paul Golding | $105 | $83.66 | -38.7% | Jul 13, 2022 |
| Morgan Stanley | Benjamin Swinburne | $110 | $97.2 | -35.8% | Jun 2, 2022 |
| Wolfe Research | Analyst unavailable | $119 | $95.54 | -30.5% | Jun 2, 2022 |
| Rosenblatt Securities | Analyst unavailable | $139 | $95.35 | -18.9% | May 6, 2022 |
| Rosenblatt Securities | Barton Crockett | $138 | $108.28 | -19.4% | Apr 28, 2022 |
| Rosenblatt Securities | Barton Crockett | $320 | $109.72 | +86.8% | Apr 26, 2022 |
| Guggenheim | Curry Baker | $140 | $116.3 | -18.3% | Mar 25, 2022 |
Track every rating change on LYV the moment it posts. Free to start.
Start freeCompany context
Snapshot as of publicationLive Nation Entertainment, Inc., incorporated in 2005 and formerly known as Live Nation, Inc. until its name change in January 2010, is a global leader in live entertainment, headquartered in Beverly Hills, California. The company's diverse operations are organized into three primary business segments: Concerts, Ticketing, and Sponsorship & Advertising. The Concerts segment is responsible for organizing and promoting live musical performances, utilizing its extensive portfolio of owned or managed venues, as well as various rented third-party locations. This division also oversees the management and operation of music venues, produces major music festivals, develops related content, and offers management and other support services to artists. Through its Ticketing segment, Live Nation manages a comprehensive suite of ticketing operations.…
Historical context
All LYV earningsLatest beats and misses
Who reports nextBeat on EPS
Missed on EPS
Get the LYV recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.
Sources
- Earnings call transcript and parsed analysis · 2026-05-11T10:29:34.698584+00:00
- FN2 earnings calendar · 2024-11-10T18:39:04.055137+00:00
- Polygon adjusted daily market bars · 2026-10-14T09:00:44.389894+00:00
- Financial Modeling Prep analyst price-target consensus and quote snapshot · 2026-10-14T09:00:44.387164+00:00
Methodology
Reported and consensus figures come from FN2's earnings event records. Market reaction and volume are calculated from daily adjusted bars around the event; abnormal move subtracts the SPY move over the same window.
Analyst target low, average, and high values are derived at request time from each named analyst's latest persisted FMP target. The current-price marker comes from FN2's persisted market snapshot. They are sell-side estimates, not an FN2 valuation or recommendation.
Transcript intelligence is a structured synthesis of the current and prior earnings-call analyses. Missing values stay missing and are never estimated.
By FN2 Research · Updated · As of 2026-10-14. For educational purposes only; not investment advice.